NuCana (NCNA) Beginning Cash Balance (2017 - 2024)

NuCana (NCNA) reported Beginning Cash Balance of $21.9 million for Q1 2024, down 57.11% on a YoY basis from $50.9 million in Q2 2023, and down 57.11% sequentially from $50.9 million in Q1 2023.

NuCana (NCNA) Beginning Cash Balance (2017 - 2024) Analysis & Trends

NuCana (NCNA) has 8 years of Beginning Cash Balance data on file, last reported at $21.9 million in Q1 2024.

  • For the quarter ending Q1 2024, Beginning Cash Balance fell 57.11% year-over-year to $21.9 million; the trailing twelve-month figure through Dec 2024 stood at $21.9 million (changed N/A YoY), and the FY2025 full-year result was $8.9 million, down 59.59% from the prior year.
  • Beginning Cash Balance slipped to $21.9 million in Q1 2024, from $50.9 million in the prior quarter.
  • In the past five years, Beginning Cash Balance ranged from a high of $120.5 million in Q1 2021 to a low of $21.9 million in Q1 2024.
  • A 5-year average of $68.1 million and a median of $66.6 million in 2020 frame the typical range for Beginning Cash Balance.
  • Across the five-year window, Beginning Cash Balance soared 80.84% in 2021 and slumped 57.11% in 2024, its largest moves.
  • Tracing NCNA's Beginning Cash Balance over 5 years: stood at $66.6 million in 2020, then soared by 80.84% to $120.5 million in 2021, then sank by 32.87% to $80.9 million in 2022, then sank by 37.0% to $50.9 million in 2023, then tumbled by 57.11% to $21.9 million in 2024.
  • Business Quant data shows NCNA's Beginning Cash Balance at $21.9 million in Q1 2024, $50.9 million in Q1 2023, and $80.9 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 21.85 Mn
Mar 31, 2024 21.85 Mn
Mar 31, 2023 50.94 Mn
Mar 31, 2023 50.94 Mn
Mar 31, 2022 80.86 Mn
Mar 31, 2022 80.86 Mn
Mar 31, 2021 120.46 Mn
Mar 31, 2021 120.46 Mn
Mar 31, 2020 66.61 Mn
Mar 31, 2020 66.61 Mn
Mar 31, 2019 100.21 Mn
Mar 31, 2019 100.21 Mn
Mar 31, 2018 120.61 Mn
Mar 31, 2018 120.61 Mn
Mar 31, 2017 24.76 Mn
Mar 31, 2017 24.76 Mn